Alterazione del sistema dei cannabinoidi endogeni nel liquido cerebrospinale di pazienti affetti da epilessia parziale di nuova diagnosi

Translated title of the contribution: The endocannabinoid system is disregulated in untreated partial epilepsy: CSF findings

A. Romigi, M. Bari, F. Placidi, M. G. Marciani, F. Torelli, F. Izzi, C. Prosperetti, S. Zannino, M. Maccarrone

Research output: Contribution to journalArticle

Abstract

Experimental evidence shows that the administration of the endocannabinoid anandamide (AEA) can antagonize epileptic discharges in the hippocampal tissue of animal models. In this report, we measured the levels of AEA and the levels of the other endocannabinoid 2-arachidonoylglycerol (2-AG) in the cerebrospinal fluid (CSF) of drug-naïve patients with partial epilepsy.We found a significant reduction of AEA (down to ∼20%) in the CSF of epileptic patients compared with healthy controls (P <0.01). Instead, 2-AG levels were not affected (P = 0.48) and no correlation was found between AEA and either disease duration or patient age.Our results support the hypothesis of a different involvement of endocannabinoids in epilepsy.

Translated title of the contributionThe endocannabinoid system is disregulated in untreated partial epilepsy: CSF findings
Original languageItalian
Pages (from-to)259-260
Number of pages2
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number138
Publication statusPublished - 2008

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'The endocannabinoid system is disregulated in untreated partial epilepsy: CSF findings'. Together they form a unique fingerprint.

  • Cite this